Want to see JP:4934 full AI Analyst Report?
4934 Stock Chart & Stats
¥625.00
¥1.00(0.16%)
At close: 4:00 PM EDT
¥625.00
¥1.00(0.16%)
Day’s Range― - ―
52-Week Range¥576.00 - ¥927.00
Previous CloseN/A
Volume12.90K
Average Volume (3M)11.01K
Market Cap
¥5.22B
Enterprise Value¥1.65K
Total Cash (Recent Filing)¥4.84B
Total Debt (Recent Filing)¥1.24B
Price to Earnings (P/E)20.7
Beta0.71
Next Earnings
Sep 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)28.78
Shares Outstanding8,720,534
10 Day Avg. Volume8,960
30 Day Avg. Volume11,006
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)1.14
Price to Sales (P/S)0.47
P/FCF Ratio5.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)24.1
Revenue Forecast (FY)¥14.60B
Bulls Say, Bears Say
Bulls Say
High Gross MarginA 76.65% gross margin indicates durable product-level profitability and likely pricing power or low COGS. This high margin provides long-term buffer to absorb SG&A and supports reinvestment in products, marketing, or R&D even if top-line growth is uneven.
Conservative LeverageLow debt-to-equity (0.17) and a healthy equity ratio deliver financial flexibility and resilience to revenue shocks. Conservative leverage reduces solvency risk, enabling the company to fund strategic initiatives or weather downturns without large interest burdens.
Strong FCF ConversionFCF conversion near 1.0 and a material improvement in FCF indicate the company effectively turns accounting profits into cash. Durable cash generation supports capex, working capital, debt reduction, or strategic investments that strengthen long-term competitiveness.
Bears Say
Declining RevenueSustained revenue decline (-7.23%) signals weakening demand or competitive pressure in core product and service lines. Over several months this erodes scale economics, limits ability to invest for growth, and makes margin expansion harder despite high gross margins.
Low Net ProfitabilityA 2.91% net margin and weak operating margins show that SG&A or other operating costs materially erode gross profits. This structural cost pressure constrains reinvestment, limits retained earnings, and reduces buffer against future top-line weakness.
Earnings ContractionA roughly 65% EPS decline indicates sizable earnings volatility or one-off hits to profitability. Such earnings contraction reduces the company’s ability to demonstrate steady returns, complicates long-term planning, and may limit access to favorable financing or strategic investment.
Premier Anti-Aging Co., Ltd. News
4934 FAQ
What was Premier Anti-Aging Co., Ltd.’s price range in the past 12 months?
Premier Anti-Aging Co., Ltd. lowest stock price was ¥576.00 and its highest was ¥927.00 in the past 12 months.
What is Premier Anti-Aging Co., Ltd.’s market cap?
Premier Anti-Aging Co., Ltd.’s market cap is ¥5.22B.
When is Premier Anti-Aging Co., Ltd.’s upcoming earnings report date?
Premier Anti-Aging Co., Ltd.’s upcoming earnings report date is Sep 14, 2026 which is in 16 days.
How were Premier Anti-Aging Co., Ltd.’s earnings last quarter?
Premier Anti-Aging Co., Ltd. released its earnings results on Jun 12, 2026. The company reported ¥11.14 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Premier Anti-Aging Co., Ltd. overvalued?
According to Wall Street analysts Premier Anti-Aging Co., Ltd.’s price is currently Overvalued.
Does Premier Anti-Aging Co., Ltd. pay dividends?
Premier Anti-Aging Co., Ltd. does not currently pay dividends.
What is Premier Anti-Aging Co., Ltd.’s EPS estimate?
Premier Anti-Aging Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Premier Anti-Aging Co., Ltd. have?
Premier Anti-Aging Co., Ltd. has 8,720,534 shares outstanding.
What happened to Premier Anti-Aging Co., Ltd.’s price movement after its last earnings report?
Premier Anti-Aging Co., Ltd. reported an EPS of ¥11.14 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.332%.
Which hedge fund is a major shareholder of Premier Anti-Aging Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4934
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Premier Anti-Aging Co., Ltd.
Premier Anti-Aging Co., Ltd. engages in the planning, development, import, export, mail order/EC, wholesale, and retail of cosmetics, health foods, and recovery wear in Japan. The company is involved in anti-aging and recovery businesses; and manufactures and sells skin care, hair care, and inner care products. It offers its products under the DUO, CANADEL, Clayence, C+mania, Sinto, Sitrana, Reinca, and Lalaskin brands. The company was incorporated in 2009 and is headquartered in Minato, Japan.
Technical Analysis
Ivy Cosmetics Corporation
―
HABA Laboratories, Inc.
―
C'BON COSMETICS Co., Ltd.
―
I-ne CO., LTD.
―
AXXZIA, Inc.
―